Tri Locum Partners LP reported 18 holdings worth US$506M as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Tri Locum Partners LP reported 18 holdings worth US$506M as of Sep 30, 2026. Largest: Vertex Pharmaceuticals Incorporated, Eli Lilly and Company and Teva Pharmaceutical Industries Limited. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 18
- Value as reported
- US$506M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | 133K | US$69.5M | 13.7% |
| Eli Lilly and Company | 51,015 | US$59M | 11.7% |
| Teva Pharmaceutical Industries Limited | 1.22M | US$48.5M | 9.6% |
| Amneal Pharmaceuticals, Inc. | 2.33M | US$46.9M | 9.3% |
| DexCom, Inc. | 489K | US$42.2M | 8.3% |
| argenx SE | 30,399 | US$29.1M | 5.8% |
| Axsome Therapeutics, Inc. | 143K | US$26.4M | 5.2% |
| Johnson & Johnson | 73,559 | US$19.5M | 3.8% |
| Enliven Therapeutics, Inc. | 410K | US$18.8M | 3.7% |
| United Therapeutics Corporation | 33,000 | US$17.9M | 3.5% |
| Madrigal Pharmaceuticals, Inc. | 33,668 | US$17M | 3.4% |
| Celcuity Inc. | 203K | US$16.1M | 3.2% |
| Dianthus Therapeutics, Inc. | 177K | US$15.6M | 3.1% |
| Revolution Medicines, Inc. | 40,019 | US$8.21M | 1.6% |
| Definium Therapeutics, Inc. | 144K | US$5.5M | 1.1% |
| Viridian Therapeutics, Inc. | 90,107 | US$1.86M | 0.37% |
| Beta Bionics, Inc. | 0 | US$0 | 0.00% |
| Cytokinetics, Incorporated | 0 | US$0 | 0.00% |
| Intuitive Surgical, Inc. | 0 | US$0 | 0.00% |
| Tarsus Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC